Spots Global Cancer Trial Database for Erectile Rating During the Treatment of Rectal Cancers Localized

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Erectile Rating During the Treatment of Rectal Cancers Localized

Official Title: Erectile Rating During the Treatment of Rectal Cancers Localized. Exploratory Study

Study ID: NCT01843218

Conditions

Rectal Cancer Stage I

Interventions

Evaluation of erectile dysfunction

Study Description

Brief Summary: Erectile dysfunction will be explored by recording R / P and self-administered questionnaire IIEF-5.

Detailed Description: Erectile dysfunction will be explored by recording R / P and self-administered questionnaire IIEF-5. This dual evaluation will be made before the beginning of the therapeutic treatment and 3 months and 12 months after surgery. Assessed by IIEF-5 will be made only 6, 18 and 24 months after surgery. There will be no changes made to support oncology patients.